1/16
07:20 am
fbio
Fortress Biotech (NASDAQ:FBIO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Fortress Biotech (NASDAQ:FBIO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/13
07:45 am
fbio
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
High
Report
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
12/15
08:10 am
fbio
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission [Yahoo! Finance]
Medium
Report
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission [Yahoo! Finance]
12/15
08:00 am
fbio
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
High
Report
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
12/9
04:24 pm
fbio
Fortress Biotech (NASDAQ:FBIO) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Fortress Biotech (NASDAQ:FBIO) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
11/23
02:11 am
fbio
Fortress Biotech (NASDAQ:FBIO) was upgraded by analysts at
Wall Street Z
Low
Report
Fortress Biotech (NASDAQ:FBIO) was upgraded by analysts at
Wall Street Z
11/14
09:35 am
fbio
Fortress Biotech GAAP EPS of $0.11, revenue of $17.6M [Seeking Alpha]
Medium
Report
Fortress Biotech GAAP EPS of $0.11, revenue of $17.6M [Seeking Alpha]
11/14
08:41 am
fbio
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
11/14
08:30 am
fbio
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
High
Report
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
11/11
05:42 pm
fbio
Fortress Biotech Q3 Earnings Preview [Seeking Alpha]
Low
Report
Fortress Biotech Q3 Earnings Preview [Seeking Alpha]
10/28
10:00 am
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
10/23
10:00 am
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
10/21
08:30 am
fbio
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
Low
Report
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
10/18
10:00 am
fbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO